WEIGAO GROUP spends HKD 0.99 million to repurchase 308,400 H shares, trimming free float by 0.0069%

Bulletin Express06-17

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) reported a share buy-back on 17 June 2026, acquiring 308,400 H shares on the Hong Kong Stock Exchange.

• Transaction details – Purchase method: On-market repurchase – Price range: HKD 3.18–3.22 per share – Volume-weighted average price: HKD 3.2014 per share – Total consideration: HKD 0.99 million

• Impact on share capital – Outstanding shares (excluding treasury) decreased from 4,463.53 million to 4,463.22 million. – Treasury shares increased from 58.81 million to 59.11 million. – The reduction represents 0.0069% of the company’s issued share capital (excluding treasury shares) prior to the transaction. – Total issued shares remained unchanged at 4,522.33 million.

• Mandate utilisation – Shareholders authorised up to 446.46 million shares for repurchase on 29 May 2026. – Cumulative buy-backs under this mandate now stand at 1.79 million shares, equivalent to 0.40% of the shares outstanding on the mandate date. – In line with Hong Kong listing rules, WEIGAO GROUP is subject to a moratorium on new share issues or treasury-share sales until 17 July 2026.

The company confirmed that all repurchases were executed in compliance with the Hong Kong Stock Exchange’s Main Board Rules and other applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment